Patents Assigned to The Lauridsen Group, Inc.
  • Methods for Treating HIV-Associated Enteropathy Symptoms With Immunoglobulin/Protein Isolate
    Publication number: 20170327563
    Abstract: The present invention provides a method for treating human immunodeficiency virus (HIV)-associated enteropathy in subjects who have been on antiretroviral therapy by orally administering immunoglobulin/protein isolate.
    Type: Application
    Filed: May 10, 2016
    Publication date: November 16, 2017
    Applicant: THE LAURIDSEN GROUP, INC.
    Inventors: Eric Weaver, Gerald Klein, Audrey L. Shaw
  • METHODS AND COMPOSITIONS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE
    Publication number: 20170281598
    Abstract: The present invention provides methods for treating and preventing the reoccurrence of C. diff infection by administering an immunoglobulin concentrate in conjunction with a low protein diet.
    Type: Application
    Filed: June 22, 2017
    Publication date: October 5, 2017
    Applicant: The Lauridsen Group, Inc.
    Inventors: Eric WEAVER, Abigail HENDERSON, Christopher DETZEL
  • Methods and compositions containing at least 30% IgG and 10% or less by weight IgA for reducing lung inflammation in an animal
    Patent number: 9616091
    Abstract: The present invention provides methods for reducing, attenuating, diminishing, preventing or inhibiting pulmonary inflammation in an animal by orally administering a plasma fraction comprising at least 30% by weight IgG and 10% or less by weight IgA to said animal prior to or following exposure or challenge of the animal to an endotoxin.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: April 11, 2017
    Assignee: THE LAURIDSEN GROUP, INC.
    Inventors: Eric Weaver, Joy Campbell, Louis Russell, Miquel Moreto Pedragosa, Anna Perez-Bosque, Francisco Javier Polo Pozo, Joseph Crenshaw
  • METHOD OF ADMINISTRATING IgC COMPOSITIONS TO PROVIDE SUSTAINED LEVELS OF AMINO ACIDS
    Publication number: 20160222095
    Abstract: The present invention provides methods for providing peak plasma amino acid concentrations through administration of an oral dose of at least 20 g of immunoglobulin concentrate.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Applicant: The Lauridsen Group, Inc.
    Inventors: Eric Weaver, Abigail Henderson, Christopher Detzel
  • METHOD TO INCREASE MILK PRODUCTION BY MAMMALS
    Publication number: 20160165922
    Abstract: This invention relates to the administration of an animal immunoglobulin source to mammals such as dairy cattle to improve milk production without negatively affecting reproductive parameters.
    Type: Application
    Filed: September 14, 2015
    Publication date: June 16, 2016
    Applicant: The Lauridsen Group, Inc.
    Inventors: Francisco Javier Polo Pozo, Joy M. Campbell, Louis E. Russell, Alejandro Bach Ariza
  • Methods and Compositions for Reducing Lung Inflammation in an Animal
    Publication number: 20110135581
    Abstract: The present invention provides methods for reducing, attenuating, diminishing, preventing or inhibiting pulmonary inflammation in an animal by orally administering a plasma fraction to said animal prior to or following exposure or challenge of the animal to an endotoxin.
    Type: Application
    Filed: May 22, 2009
    Publication date: June 9, 2011
    Applicant: THE LAURIDSEN GROUP, INC.
    Inventors: Eric Weaver, Joy Campbell, Louis Russell, Miquel Moreto Pedragosa, Anna Perez-Bosque, Francisco Javier Polo Pozo, Joseph Crenshaw
  • Process for producing insoluble and soluble collagen protein products from poultry skins and use thereof
    Patent number: 6995242
    Abstract: A method of extracting and fractionating collagen-rich proteinaceous materials and derivatives from poultry skin tissue and the development of the proteinaceous materials to collagen-based protein ingredients that can function as meat replacer, texturizer, binder/filler, stabilizer, or protective colloids in processed meat products. The insoluble and soluble collagen products, collagen-based protein ingredients, water-dispersible collagen-based protein ingredients are produced by heating, separating, and rapidly cooling the solid-phase below its melting temperature to exploit reformation of the helical forms which produces a high concentration of coils, a phenomenon that accounts for its ability to form cold-set thermal reversible gels and gel strength.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: February 7, 2006
    Assignee: The Lauridsen Group, Inc.
    Inventors: Ifendu Nnanna, Allen Leinen, David Hull